Transcriptional adaptation of that survives prolonged multi-drug treatment in mice.

Journal:
mBio, Volume: 14, Issue: 6
Published:
December 19, 2023
PMID:
37905920
Authors:
Elizabeth A Wynn EA, Christian Dide-Agossou C, Matthew Reichlen M, Karen Rossmassler K, Reem Al Mubarak R, Justin J Reid JJ, Samuel T Tabor ST, Sarah E M Born SEM, Monica R Ransom MR, Rebecca M Davidson RM, Kendra N Walton KN, Jeanne B Benoit JB, Amanda Hoppers A, Dorothy E Loy DE, Allison A Bauman AA, Lisa M Massoudi LM, Gregory Dolganov G, Michael Strong M, Payam Nahid P, Martin I Voskuil MI, Gregory T Robertson GT, Camille M Moore CM, Nicholas D Walter ND
Abstract:

A major reason that curing tuberculosis requires prolonged treatment is that drug exposure changes bacterial phenotypes. The physiologic adaptations of that survive drug exposure have been obscure due to low sensitivity of existing methods in drug-treated animals. Using the novel SEARCH-TB RNA-seq platform, we elucidated phenotypes in mice treated for with the global standard 4-drug regimen and compared them with the effect of the same regimen . This first view of the transcriptome of the minority population that withstands treatment reveals adaptation of a broad range of cellular processes, including a shift in metabolism and cell wall modification. Surprisingly, the change in gene expression induced by treatment and was largely similar. This apparent “portability” from to the mouse provides important new context for transcriptional analyses that may support early preclinical drug evaluation.


Courtesy of the U.S. National Library of Medicine